| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 242,5 k € | -4.1% | 252,7 k € | +19.2% | 212,1 k € | -7.7% | 229,8 k € | +33.1% | 172,7 k € | +12.7% | 153,3 k € | +9.1% | 140,5 k € | -16.1% | 167,4 k € | +113.5% | 78,4 k € | -44.5% | 141,1 k € | +83.7% | 76,8 k € | -62.9% | 206,8 k € | +3.8% | 199,3 k € | +50.3% | 132,6 k € | |
| EBITDA | 163,7 k € | -14.0% | 190,4 k € | +64.4% | 115,8 k € | -22.5% | 149,4 k € | +42.8% | 104,6 k € | +18.6% | 88,2 k € | +63.4% | 54,0 k € | -22.8% | 70,0 k € | +960.6% | 6,6 k € | -93.2% | 97,5 k € | +159.3% | 37,6 k € | -66.2% | 111,1 k € | +2.2% | 108,8 k € | +59.0% | 68,4 k € | |
| Operating profit | 119,5 k € | -18.3% | 146,2 k € | +143.8% | 60,0 k € | -28.3% | 83,6 k € | +703.6% | 10,4 k € | +4078.7% | -261,5 € | +99.0% | -27,3 k € | -192.7% | 29,4 k € | +178.6% | -37,4 k € | -168.6% | 54,5 k € | +1197.3% | -5,0 k € | -107.0% | 70,9 k € | +3.4% | 68,6 k € | +73.6% | 39,5 k € | |
| Profit/loss | 80,3 k € | -25.5% | 107,9 k € | +169.3% | 40,1 k € | -35.8% | 62,4 k € | +533.4% | 9,8 k € | +1260.5% | 723,5 € | +103.0% | -24,5 k € | -159.9% | 40,9 k € | +1001.7% | -4,5 k € | -107.8% | 57,8 k € | +256.6% | 16,2 k € | -72.9% | 59,9 k € | +0.7% | 59,5 k € | +64.9% | 36,1 k € | |
| Equity | 459,8 k € | +21.2% | 379,5 k € | +3.4% | 366,9 k € | +12.3% | 326,9 k € | +23.6% | 264,5 k € | +3.9% | 254,7 k € | +0.3% | 253,9 k € | -8.8% | 278,4 k € | +17.2% | 237,5 k € | -1.9% | 242,1 k € | +31.4% | 184,2 k € | +9.7% | 168,0 k € | +55.5% | 108,1 k € | +122.7% | 48,5 k € | |
| Total assets | 809,0 k € | -4.1% | 844,0 k € | +11.6% | 756,1 k € | -5.5% | 799,9 k € | -39.7% | 1,3 M € | +27.2% | 1,0 M € | +5.2% | 990,8 k € | +49.6% | 662,4 k € | -16.9% | 797,4 k € | +10.4% | 722,3 k € | +4.9% | 688,7 k € | -4.7% | 722,8 k € | +8.9% | 663,8 k € | +7.2% | 619,1 k € | |
| Cash | 149,2 k € | -21.1% | 189,0 k € | +81.4% | 104,2 k € | -14.5% | 121,9 k € | -81.1% | 645,2 k € | +94.5% | 331,7 k € | +28.8% | 257,5 k € | +13.2% | 227,4 k € | -36.2% | 356,4 k € | +35.2% | 263,5 k € | +28.4% | 205,2 k € | -20.1% | 256,9 k € | +67.8% | 153,1 k € | +110.8% | 72,6 k € | |
| Debts | 348,5 k € | -24.8% | 463,5 k € | +21.0% | 383,1 k € | -15.3% | 452,6 k € | -56.8% | 1,0 M € | +33.3% | 786,2 k € | +8.0% | 728,1 k € | +95.1% | 373,2 k € | -29.4% | 528,8 k € | +13.5% | 465,9 k € | +22.0% | 381,9 k € | -29.9% | 544,4 k € | -2.0% | 555,4 k € | -0.9% | 560,6 k € | |
| Staff | 1 | 0,9 | 1,5 | 1,4 | 1,4 | 1,4 | — | 1,4 | 1,1 | 0,6 | 0,5 | 0,7 | 1,2 | 0,9 | ||||||||||||||
Private limited company · Meise · incorporated on 02/03/2012 · 1,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-21.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK HOPLAND is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Meise. It employs on average 1,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette